Meet our team
dr. Črtomir Podlipnik
His research interest and focus is on exploring relevant biomolecular systems, and with his valuable comprehensive knowledge in the field he is actively involved in a number of projects, including ebola research.
dr. Marko Jukić
Assistant Professor in the field of pharmaceutical chemistry, working at the Faculty of Chemistry and Chemical Technology, University of Maribor. Founder of bio-information company IntelliMol. He is involved in the design of new active substances, bioinformatics and the development of computer tools for the design of new drugs.
dr. Natalia Nikitina
Karelian Research Center
Master’s student. He mostly works in the field of bioinformatics, identifying possible targets for novel drug development. Together with dr. Podlipnik he has worked on anti-Ebola research prior to this project.
Master’s student at the University of Milan. He is primarily engaged in molecular simulations of biomolecular systems. He is also collaborating with BioSolveIT company in the project: Targeting for new therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Pharmacy student at the University of Ljubljana, and a programmer. He has always been interested in medicine, viruses and organic chemistry. The desire for challenges and helping people led him to participate in research on the current epidemic.
Bachelor of Science in Computer and Information Science, currently the Head of Development at 1Home, which is involved in connecting smart homes with voice assistants. He is interested in technology and everything related to it.
Businessman, programmer, he mostly works on development of specific applications for Windows. A researcher by heart, curiosity and humanitarianism led him to his role in the covid.si project.
Specialist in IT, he supports the server side of distributed computing and constructs amateur computational clusters. He has been participating in volunteer computing for many years.
Award winning writer, bachelor of organic chemistry and jack of all trades. He joined the COVID.si project out of his interest in the novel coronavirus and wish to help humanity.